3-Cyanochromone

CAS No. 50743-17-4

3-Cyanochromone ( —— )

Catalog No. M14733 CAS No. 50743-17-4

3-Cyanochromone is a potent gram-negative bacteria WcbL protein inhibitor with IC50 of 28 uM in a competitive enzyme-inhibition model.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
100MG Get Quote Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    3-Cyanochromone
  • Note
    Research use only, not for human use.
  • Brief Description
    3-Cyanochromone is a potent gram-negative bacteria WcbL protein inhibitor with IC50 of 28 uM in a competitive enzyme-inhibition model.
  • Description
    3-Cyanochromone is a potent gram-negative bacteria WcbL protein inhibitor with IC50 of 28 uM in a competitive enzyme-inhibition model, shows inhibition constants Ki of 10 uM.
  • Synonyms
    ——
  • Pathway
    GPCR/G Protein
  • Target
    Antibacterial
  • Recptor
    Antibacterial
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    50743-17-4
  • Formula Weight
    171.15
  • Molecular Formula
    C10H5NO2
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    C1=CC=C2C(=C1)C(=O)C(=CO2)C#N
  • Chemical Name
    4-Oxo-4H-1-benzopyran-3-carbonitrile

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Vivoli M, et al. Chem Biol. 2015 Dec 17;22(12):1622-32.
molnova catalog
related products
  • Ceftobiprole medocar...

    Ceftobiprole medocaril is the parenteral prodrug of Ceftobiprole. Ceftobiprole is a broad-spectrum cephalosporin with activity against Methicillin-resistant staphylococcus aureus (MRSA).

  • Sulfachloropyrazine ...

    Sulfachloropyrazine sodium is an antiprotozoalwith antibacterial and anticoccidial effects.

  • Norlichexanthone

    Norlichexanthone has the potential to treat and/or prevent lifestyle-related diseases such as type 2 diabetes, metabolic syndrome, atherosclerosis and cardiovascular disease.